1. Home
  2. TOVX vs IRIX Comparison

TOVX vs IRIX Comparison

Compare TOVX & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.14

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

N/A

Current Price

$0.66

Market Cap

12.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOVX
IRIX
Founded
2001
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
12.6M
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
TOVX
IRIX
Price
$0.14
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.1M
26.0K
Earning Date
11-12-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.07
51.85
EPS
N/A
★ N/A
Revenue
N/A
★ $41,593,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.14
$0.61
52 Week High
$0.49
$1.65

Technical Indicators

Market Signals
Indicator
TOVX
IRIX
Relative Strength Index (RSI) 30.97 47.45
Support Level $0.14 $0.70
Resistance Level $0.25 $0.78
Average True Range (ATR) 0.02 0.05
MACD -0.00 -0.00
Stochastic Oscillator 14.48 38.49

Price Performance

Historical Comparison
TOVX
IRIX

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About IRIX IRIDEX Corporation

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: